Nashat Amir
- SEC CIK
- 0001575843
No open-market purchases or sales filed in the past year.
Current role at each company
- CAMP Camp4 Therapeutics CorpDirector, 10% Owneras of Jun 12, 2026
- MORF Morphic Holding, Inc.Directoras of Aug 20, 2024
- SRRK Scholar Rock Holding CorpDirectoras of May 13, 2024
- MTCR Metacrine, Inc.Director, 10% Owneras of Sep 6, 2022
- SYRS Syros Pharmaceuticals, Inc.Directoras of Jun 2, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Nashat Amir as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CAMP Camp4 Therapeutics Corp
Director, 10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2025 (view filing) | Sep 11 | Same day | Nashat AmirDirector, 10% Owner | PPurchase | +1.31M | $1.53 | +$2.00M | New position197.7K after | 2 lots |
| Oct 15, 2024 (view filing) | Oct 15 | Same day | Nashat AmirDirector, 10% Owner | PPurchase | +909.1K | $11.00 | +$10.0M | New position909.1K after |
SRRK Scholar Rock Holding Corp
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 24, 2022 (view filing) | Jun 22 | 2 days | Nashat AmirDirector | PPurchase | +1.20M | $4.90 | +$5.87M | New position206.9K after | 2 lots |
| Jun 24, 2022 (view filing) | Jun 22 | 2 days | Nashat AmirDirector | PPurchase | +299.5K | $4.90 | +$1.47M | –16.5K after | Derivative2 lots |